Corcept Therapeutics Inc

Business Description

Corcept Therapeutics is a US-based pharmaceutical company focused on developing drugs that work by blocking the effects of cortisol, a hormone that can cause serious harm when present at excessive levels in the body. Its flagship product, Korlym, is an approved oral treatment for adults with Cushing's syndrome whose high blood sugar cannot be managed through surgery. The company also has several drugs in various stages of clinical testing targeting conditions such as liver disease and ALS. Founded in 1998 and based in Redwood City, California, Corcept holds a broad portfolio of cortisol-blocking compounds with potential applications across a range of serious illnesses.